Analyst firms · Barclays · ZTS

Barclays ZTS price target and rating history

Zoetis Inc. (ZTS) · Health Care

Barclays rates Zoetis Inc. (ZTS) Equal Weight with a $136 price target, as of its latest action on Dec 9, 2025. It has published 3 rating actions on ZTS since August 2021, including 0 upgrades and 0 downgrades. Across 6 firms with a ZTS price target in the last 12 months, the median target is $135. Barclays's $136 is 1% above that.

Current rating

Equal Weight

Price target

$136

Median target, all firms

$135

Actions on ZTS

3

Barclays price target on ZTS

Every Barclays rating on ZTS

• Dec 9, 2025
  InitiateBarclays starts coverage at Equal Weight, price target $136
• Nov 5, 2021
  ReiterateBarclays raises its price target to $240 from $235, keeps Overweight
• Aug 6, 2021
  ReiterateBarclays raises its price target to $235 from $208, keeps Overweight

How other firms rate ZTS

Each firm's latest rating and stated target in the last 12 months.

Questions about Barclays and ZTS

What is Barclays's price target for ZTS?

Barclays's latest stated price target for Zoetis Inc. (ZTS) is $136, from its action on Dec 9, 2025.

What is Barclays's rating on ZTS?

Barclays rates ZTS Equal Weight, a neutral rating, as of Dec 9, 2025.

When did Barclays last change its view on ZTS?

On Dec 9, 2025, Barclays starts coverage at Equal Weight, price target $136.

How does Barclays's ZTS target compare with other analysts?

Across 6 firms with a ZTS price target in the last 12 months, the median target is $135. Barclays's $136 is 1% above that.

More ZTS rating histories

• Citigroup3

All Barclays ratingsZTS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.